GM1 gangliosidosis type 1
General Information (adopted from Orphanet):
Synonyms, Signs: |
GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM BETA-GALACTOSIDASE-1 DEFICIENCY GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1 GLB1 DEFICIENCY GM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I Norman-Landing disease Infantile GM1 gangliosidosis |
Number of Symptoms | 31 |
OrphanetNr: | 79255 |
OMIM Id: |
230500
|
ICD-10: |
E75.1 |
UMLs: |
|
MeSH: |
|
MedDRA: |
|
Snomed: |
238026007 |
Prevalence, inheritance and age of onset:
Prevalence: | No data available. |
Inheritance: |
Autosomal recessive [Orphanet] |
Age of onset: |
Neonatal Infancy [Orphanet] |
Disease classification (adopted from Orphanet):
Parent Diseases: |
GM1 gangliosidosis
-Rare bone disease -Rare eye disease -Rare genetic disease -Rare neurologic disease |
Symptom Information:
|
(HPO:0000212) | Gingival overgrowth | 43 / 7739 | ||||
|
(HPO:0000470) | Short neck | 345 / 7739 | ||||
|
(HPO:0000316) | Hypertelorism | 644 / 7739 | ||||
|
(HPO:0000457) | Depressed nasal ridge | 85 / 7739 | ||||
|
(HPO:0000280) | Coarse facial features | 189 / 7739 | ||||
|
(HPO:0001249) | Intellectual disability | 1089 / 7739 | ||||
|
(HPO:0001387) | Joint stiffness | 322 / 7739 | ||||
|
(HPO:0002808) | Kyphosis | 289 / 7739 | ||||
|
(HPO:0008479) | Hypoplastic vertebral bodies | 12 / 7739 | ||||
|
(HPO:0002650) | Scoliosis | 705 / 7739 | ||||
|
(HPO:0004568) | Beaking of vertebral bodies | 19 / 7739 | ||||
|
(HPO:0000900) | Thickened ribs | 9 / 7739 | ||||
|
(HPO:0000023) | Inguinal hernia | 181 / 7739 | ||||
|
(HPO:0002240) | Hepatomegaly | 467 / 7739 | ||||
|
(HPO:0001744) | Splenomegaly | 337 / 7739 | ||||
|
(HPO:0003510) | Severe short stature | 90 / 7739 | ||||
|
(HPO:0000998) | Hypertrichosis | 52 / 7739 | ||||
|
(HPO:0001071) | Angiokeratoma corporis diffusum | 7 / 7739 | ||||
|
(HPO:0001644) | Dilated cardiomyopathy | 141 / 7739 | ||||
|
(HPO:0001654) | Abnormality of the heart valves | 49 / 7739 | ||||
|
(HPO:0001635) | Congestive heart failure | 232 / 7739 | ||||
|
(HPO:0001639) | Hypertrophic cardiomyopathy | 137 / 7739 | ||||
|
(HPO:0001922) | Vacuolated lymphocytes | 13 / 7739 | ||||
|
(HPO:0008166) | Decreased beta-galactosidase activity | 6 / 7739 | ||||
|
(HPO:0007313) | Cerebral degeneration | 4 / 7739 | ||||
|
(OMIM) | Clear cornea | 6 / 7739 | ||||
|
(OMIM) | No mucopolysacchariduria | 4 / 7739 | ||||
|
(OMIM) | Glomerular epithelial cytoplasmic vacuolization | 1 / 7739 | ||||
|
(OMIM) | Full forehead | 2 / 7739 | ||||
|
(OMIM) | Cherry-red spot in half the patients | 1 / 7739 | ||||
|
(OMIM) | Dermal melanocytosis | 2 / 7739 |
Associated genes:
ClinVar (via SNiPA)
Gene symbol | Variation | Clinical significance | Reference |
---|
Additional Information:
Description: (OMIM) |
GM1-Gangliosidosis is an autosomal recessive lysosomal storage disease characterized by accumulation of ganglioside substrates in lysosomes. Clinically, patients show variable degrees of neurodegeneration and skeletal abnormalities. There are 3 main clinical variants categorized by severity and variable residual ... |
Clinical Description OMIM |
Landing et al. (1964) gave the first definitive description of this entity, which had variously been called 'Hurler variant,' 'pseudo-Hurler disease,' and 'Tay-Sachs disease with visceral involvement.' O'Brien et al. (1965) suggested the designation 'generalized gangliosidosis.' Clinical features ... |
Genotype-Phenotype Correlations OMIM |
Hinek et al. (2000) performed expression studies on 2 nonsense GLB1 mutations resulting in GM1-gangliosidosis with cardiac involvement (see, e.g., R351X; 611458.0019). Both mutations resulted in impairment of the lysosomal and EBP protein regions and showed no EBP ... |
Molecular genetics OMIM |
Yoshida et al. (1991) and Nishimoto et al. (1991) independently identified mutations in the GLB1 gene in Japanese patients with various forms of GM1 gangliosidosis. Those with the infantile form had specific mutations (611458.0001; 611458.0002; 611458.0005-611458.0007). Residual enzyme ... |